Novel 5-pyrrolyl-6-halogeno-2- pyridylmethylsufinylbenzimidazole

1. The invention relates to a compound having the general formula (I): (CF DRAWING IN BOPI) and pharmaceutically acceptable salts thereof, wherein: X represents including S, Y represents halogen, R1 and R2, independently of one another, in particular hydrogen, R3 especially represents hydrogen, R6 represents particular an alkyl C1 - C4 R7 is especially hydrogen, Z especially represents a group of formula -O (CH 2) p -OR 8, wherein: p represents an integer of 1 to 3, R8 represents in particular a hydrogen, m represents an integer from 2 to 10, and R4 and R5, independently of one another are in particular hydrogen. These compounds are useful for the preparation of anti-ulcer drugs.